PHOSPHOROUS

Back

CLINICAL SIGNIFICANCE
The concentration of phosphorus in serum increases in osteolytic metastatic bone tumors, myelogenous leukemia, sarkoidosis, vitamin D intoxication, renal failure, hypoparathyroidism, pseudohypoparathyroidism, diabetes mellitus with ketosis, acromegaly, malignant hyperpyrexia following anesthesia, pulmonary embolism, portal cirrhosis, lactic acidosis, respiratory acidosis, healing fractures.

Phosphorus levels decrease in osteomalacia, steatorrhea, renal tubular acidosis, growth hormone deficiency, acute alcoholism, Gram-negative bacterial septicemia, hypokalemia, familial hypophosphatemic rickets, severe malnutrition, malabsorption, diarrhea, vomiting, nasogastric suction, primary hyperparathyroidism, PTH-producing tumors, familial hypocalciouric hypercalciemia, severe hypercalciemia of any cause, acute gout, respiratory infections, hyperinsulinemia, respiratory infections or alkalosis, osteoblastic metastases of cancer, renal tubular defects, diuretic phase of severe burns.
CHARACTERISTICS

Form: Liquid, ready to use
Shelf life: 24 months @ 2-8 C
On-Board Stability: 60 days
Sample: Fresh, non lipemic, non hemolysed serum or heparinized plasma
Detection limit: 0.01 mg/dL
Linearity: 0.18–15.0 mg/dL


Packaging
For Use On
MEDILYZER
EX-OLYMPUS
GENERAL PURPOSE
SIEMENS ADVIA
Packaging
8x70 Tests
4x100 Tests & 4x500 Tests
Please Request Info
4x300 Tests & 4x600 Tests